» Authors » Akira Nakazato

Akira Nakazato

Explore the profile of Akira Nakazato including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 10
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mizukami T, Yamagishi K, Tobikawa M, Nakazato A, Abe H, Morita Y, et al.
Curr Oncol . 2024 May; 31(5):2636-2643. PMID: 38785479
Background: The aim of this study is to examine the outcomes of an accelerated fractionated irradiation for N0 glottic carcinoma. Methods: In this retrospective analysis, 29 patients with N0 glottic...
2.
Mochizuki M, Shibuya-Takahashi R, Kanno S, Adachi S, Fujimori H, Nakazato A, et al.
Cancer Sci . 2024 May; 115(7):2346-2359. PMID: 38710200
RNAs, such as noncoding RNA, microRNA, and recently mRNA, have been recognized as signal transduction molecules. CD271, also known as nerve growth factor receptor, has a critical role in cancer,...
3.
Tram Anh D, Takakura H, Nakazato A, Morita Y, Shojaku H
Acta Otolaryngol . 2023 Nov; 143(10):840-844. PMID: 37995205
Background: Long-term efficacy of middle ear pressure therapy (MEPT) with the EFET01 device in patients in Japan with definitive Ménière's disease (MD) and delayed endolymphatic hydrops (DEH) was evaluated. Objective:...
4.
Tram Anh D, Takakura H, Nakazato A, Shojaku H
Acta Otolaryngol . 2023 Aug; 143(8):655-661. PMID: 37537955
Background: As a low-cost, portable, handheld air pressure generation tool not requiring a ventilation tube, the EFET01 device has shown clinical effectiveness for intractable Ménière's disease (MD) patients in Japan....
5.
Nakazato A, Mochizuki M, Shibuya-Takahashi R, Fujimori H, Fujii K, Saijoh S, et al.
Sci Rep . 2022 Oct; 12(1):17751. PMID: 36273237
CD271 (also referred to as nerve growth factor receptor or p75) is expressed on cancer stem cells in hypopharyngeal cancer (HPC) and regulates cell proliferation. Because elevated expression of CD271...
6.
Nakazato A, Takakura H, Ueda N, Do T, Takeda N, Watanabe Y, et al.
Acta Otolaryngol . 2022 Jun; 142(6):491-498. PMID: 35723676
Background: Middle ear pressure therapy (MEPT) is effective for intractable vertigo in patients with definite Meniere's disease (MD) and treatment-refractory delayed endolymphatic hydrops (DEH). Four-month MEPT with the EFET01, an...
7.
Nakazato A, Takakura H, Do T, Ueda N, Takeda N, Watanabe Y, et al.
Acta Otolaryngol . 2022 May; 142(5):388-394. PMID: 35544580
Background: Middle ear pressure therapy (MEPT) is effective in treating intractable vertigo in patients with definite Meniere's disease (MD) and delayed endolymphatic hydrops (DEH) refractory to conservative treatment. A novel...
8.
Ito S, Hashimoto A, Yamaguchi K, Kawamura S, Myoen S, Ogawa M, et al.
Mol Genet Genomic Med . 2022 Feb; 10(3):e1884. PMID: 35128829
Carney complex (CNC) is a rare hereditary syndrome that involves endocrine dysfunction and the development of various types of tumors. Chromosome 2p16 and PRKAR1A on chromosome 17 are known susceptibility...
9.
Imai T, Saijo S, Fujii K, Nakazato A, Nakamura K, Miyakura Y, et al.
Auris Nasus Larynx . 2021 Jul; 49(1):141-146. PMID: 34218974
Objective: Early enteral nutrition is essential for enhancing recovery after surgery. However, to date, no detailed study has been conducted on the feasibility of early enteral nutrition in patients undergoing...
10.
Takakura H, Hamashima T, Tachino H, Nakazato A, Minato H, Sasahara M, et al.
Front Surg . 2020 Dec; 7:596796. PMID: 33330610
Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma (TL-LGNPPA) is an extremely rare neoplasm of the nasopharynx. Accordingly, its clinical and pathological characteristics are not well-known. We report a case of TL-LGNPPA and...